News headlines about Metlife (NYSE:MET) have been trending somewhat positive on Sunday, according to Accern Sentiment. The research firm scores the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Metlife earned a daily sentiment score of 0.08 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 48.1129026393291 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
Here are some of the news headlines that may have effected Accern’s rankings:
Metlife (NYSE MET) opened at $53.33 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.31. Metlife has a 12 month low of $44.43 and a 12 month high of $55.91. The company has a market cap of $56,119.11, a P/E ratio of -106.66, a price-to-earnings-growth ratio of 1.20 and a beta of 1.49.
Metlife (NYSE:MET) last released its quarterly earnings results on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, topping the Zacks’ consensus estimate of $0.90 by $0.19. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The business had revenue of $16.10 billion during the quarter, compared to analysts’ expectations of $15.47 billion. During the same quarter in the previous year, the company earned $1.28 EPS. The business’s quarterly revenue was up 1.7% compared to the same quarter last year. sell-side analysts expect that Metlife will post 4.4 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be paid a $0.40 dividend. The ex-dividend date is Friday, February 2nd. This represents a $1.60 dividend on an annualized basis and a yield of 3.00%. Metlife’s dividend payout ratio is presently -320.00%.
Several analysts have recently issued reports on the stock. Goldman Sachs Group assumed coverage on shares of Metlife in a research report on Wednesday, October 18th. They issued a “conviction-buy” rating and a $61.00 price target on the stock. ValuEngine lowered shares of Metlife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 9th. Zacks Investment Research lowered shares of Metlife from a “hold” rating to a “sell” rating in a research report on Tuesday, January 2nd. Royal Bank of Canada reissued an “outperform” rating and issued a $60.00 price target (up previously from $56.00) on shares of Metlife in a research report on Friday, November 3rd. Finally, TheStreet raised shares of Metlife from a “c+” rating to a “b” rating in a research report on Wednesday, October 4th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $57.90.
In other news, insider Christopher G. Townsend sold 82,731 shares of the company’s stock in a transaction on Friday, November 3rd. The shares were sold at an average price of $54.60, for a total value of $4,517,112.60. Following the completion of the sale, the insider now owns 49,660 shares of the company’s stock, valued at approximately $2,711,436. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christopher G. Townsend sold 55,712 shares of the company’s stock in a transaction on Monday, November 6th. The shares were sold at an average price of $54.29, for a total transaction of $3,024,604.48. Following the completion of the sale, the insider now directly owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The disclosure for this sale can be found here. 0.32% of the stock is owned by insiders.
WARNING: “Metlife (NYSE:MET) Given Media Impact Score of 0.08” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/01/14/metlife-met-earning-somewhat-favorable-news-coverage-accern-reports.html.
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.